Tamoxifen
Back to searchMolecule Structure
Scientific Name
Tamoxifen
Description of the Drug
Tamoxifen is a selective estrogen receptor modulator used to treat estrogen receptor positive breast cancer, reduce the risk of invasive breast cancer following surgery, or reduce the risk of breast cancer in high risk women.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00675
http://www.drugbank.ca/drugs/DB00675
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Teva Pharmaceuticals Usa Inc, Astrazeneca Pharmaceuticals Lp, Actavis Laboratories Fl Inc, Mayne Pharma Inc, Eugia Pharma Specialities Ltd, Aegis Pharmaceuticals Inc, Roxane Laboratories Inc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Estrogen receptor alpha | SINGLE PROTEIN | MODULATOR | CHEMBL206 |
Clinical Trial(s)
Unichem Links
| Atlas | tamoxifen | ||||||
| SureChEMBL | SCHEMBL4084 | ||||||
| PharmGKB | PA451581 | ||||||
| Human Metabolome Database | HMDB0014813 | ||||||
| DrugBank | DB00675 | ||||||
| PubChem: Thomson Pharma | 14853108 | ||||||
| PubChem | 2733526 | ||||||
| NMRShiftDB | 60027680 | ||||||
| LINCS | LSM-42959 | ||||||
| Nikkaji | J238.685B | J10.452C | J75.058A | ||||
| PDBe | CTX | ||||||
| BindingDB | 20607 | ||||||
| EPA CompTox Dashboard | DTXSID1034187 | ||||||
| DrugCentral | 2561 | ||||||
| Brenda | 78063 | 54572 | 230113 | 36584 | 1629 | 230114 | 220072 |
| ChemicalBook | CB9438781 | ||||||
| Guide to Pharmacology | 5384 | 1016 | |||||
| rxnorm | TAMOXIFEN | TAMOXIFEN CITRATE | SOLTAMOX | NOLVADEX | |||
| KEGG Ligand | C07108 | ||||||
| ChEBI | 41774 | ||||||
| ZINC | ZINC000001530689 |
